Live feed08:00:00·1hPRReleasevia QuantisnowRadiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101ByQuantisnow·Wall Street's wire, on your screen.RADX· Radiopharm Theranostics LimitedHealth Care
